| 2026-10-21 | Eingeleitet | DA Davidson | Neutral |
| 2026-09-11 | Resumed | Wedbush | Outperform |
| 2026-09-04 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-06-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2026-05-27 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-05-27 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2026-05-18 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2026-04-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2026-04-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2026-03-03 | Eingeleitet | Wells Fargo | Overweight |
| 2026-02-27 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-02-13 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-12-16 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-12-01 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2025-11-26 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2025-11-26 | Bestätigt | Needham | Buy |
| 2025-11-18 | Eingeleitet | Berenberg | Buy |
| 2025-09-03 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-09-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-08-26 | Eingeleitet | B. Riley Securities | Neutral |
| 2025-06-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-05-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-04-28 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2025-04-23 | Eingeleitet | Roth Capital | Neutral |
| 2025-04-03 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-04-01 | Eingeleitet | Stephens | Overweight |
| 2025-03-18 | Resumed | Morgan Stanley | Equal-Weight |
| 2025-03-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-03-06 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-03-06 | Hochstufung | Rosenblatt | Neutral → Buy |
| 2024-12-03 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-10-08 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2024-09-04 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-09-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-07-23 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-07-16 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-06-14 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-06-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-05-28 | Herabstufung | Rosenblatt | Buy → Neutral |
| 2024-05-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-04-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-01-18 | Eingeleitet | Bernstein | Outperform |
| 2024-01-17 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-01-03 | Bestätigt | Oppenheimer | Outperform |
| 2023-12-15 | Eingeleitet | Susquehanna | Positive |
| 2023-12-12 | Hochstufung | Macquarie | Neutral → Outperform |
| 2023-11-28 | Bestätigt | Needham | Strong Buy |
| 2023-10-19 | Hochstufung | Jefferies | Hold → Buy |
| 2023-10-09 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-10-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-07-25 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-06-08 | Eingeleitet | Oppenheimer | Outperform |
| 2023-05-02 | Eingeleitet | Rosenblatt | Buy |
| 2023-03-17 | Eingeleitet | CapitalOne | Equal Weight |
| 2023-02-14 | Eingeleitet | Goldman | Neutral |
| 2023-01-24 | Eingeleitet | JP Morgan | Neutral |
| 2023-01-18 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-01-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-12-01 | Eingeleitet | Redburn | Neutral |
| 2022-11-02 | Eingeleitet | Macquarie | Neutral |
| 2022-10-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2022-10-19 | Resumed | Robert W. Baird | Outperform |
| 2022-10-07 | Eingeleitet | SMBC Nikko | Outperform |
| 2022-10-06 | Eingeleitet | Evercore ISI | Outperform |
| 2022-09-22 | Eingeleitet | MoffettNathanson | Hold |
| 2022-09-16 | Eingeleitet | MKM Partners | Buy |
| 2022-09-15 | Eingeleitet | Jefferies | Hold |
| 2022-08-12 | Eingeleitet | Guggenheim | Buy |
| 2022-07-26 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-05-26 | Eingeleitet | Stephens | Overweight |
| 2022-03-02 | Hochstufung | Daiwa Securities | Underperform → Buy |
| 2022-02-25 | Bestätigt | BMO Capital Markets | Outperform |
| 2022-02-25 | Bestätigt | BTIG Research | Buy |
| 2022-02-25 | Bestätigt | BofA Securities | Buy |
| 2022-02-25 | Bestätigt | Deutsche Bank | Buy |
| 2022-02-25 | Bestätigt | FBN Securities | Outperform |
| 2022-02-25 | Bestätigt | JP Morgan | Underweight |
| 2022-02-25 | Bestätigt | Mizuho | Buy |
| 2022-02-25 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-02-25 | Bestätigt | Robert W. Baird | Outperform |
| 2022-02-25 | Bestätigt | Stifel | Buy |
| 2022-02-25 | Bestätigt | UBS | Buy |
| 2022-02-25 | Bestätigt | Wedbush | Outperform |
| 2022-02-25 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-25 | Bestätigt | Wolfe Research | Outperform |
| 2022-02-22 | Resumed | JMP Securities | Mkt Outperform |
| 2022-01-25 | Eingeleitet | Citigroup | Buy |
| 2022-01-21 | Eingeleitet | Stifel | Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-10 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-06 | Herabstufung | Daiwa Securities | Neutral → Underperform |
| 2021-11-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-09-30 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-09-10 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-09-10 | Bestätigt | BTIG Research | Buy |
| 2021-09-10 | Bestätigt | BofA Securities | Buy |
| 2021-09-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-09-10 | Bestätigt | Cowen | Outperform |
| 2021-09-10 | Bestätigt | Deutsche Bank | Buy |
| 2021-09-10 | Bestätigt | Mizuho | Buy |
| 2021-09-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-09-10 | Bestätigt | Piper Sandler | Neutral |
| 2021-09-10 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-10 | Bestätigt | UBS | Neutral |
| 2021-08-06 | Eingeleitet | Wolfe Research | Outperform |
| 2021-07-26 | Herabstufung | Loop Capital | Buy → Hold |
| 2021-07-15 | Bestätigt | Canaccord Genuity | Buy |
| 2021-05-27 | Eingeleitet | Cowen | Outperform |
| 2021-05-26 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-04-13 | Eingeleitet | Mizuho | Buy |
| 2021-03-24 | Hochstufung | Truist | Hold → Buy |
| 2021-03-16 | Resumed | Credit Suisse | Outperform |
| 2021-03-05 | Hochstufung | Berenberg | Hold → Buy |
| 2021-02-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-02-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-01-20 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-01-12 | Bestätigt | Needham | Strong Buy |
| 2020-12-10 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-10 | Bestätigt | Needham | Strong Buy |
| 2020-11-25 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-10-26 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-21 | Eingeleitet | Loop Capital | Buy |
| 2020-08-20 | Eingeleitet | Deutsche Bank | Buy |
| 2020-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-07-06 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-06-22 | Bestätigt | Needham | Strong Buy |
| 2020-06-18 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-06-16 | Herabstufung | Berenberg | Buy → Hold |
| 2020-05-29 | Bestätigt | BofA/Merrill | Buy |
| 2020-05-29 | Bestätigt | Cowen | Outperform |
| 2020-05-29 | Bestätigt | Credit Suisse | Neutral |
| 2020-05-29 | Bestätigt | Needham | Strong Buy |
| 2020-05-29 | Bestätigt | Robert W. Baird | Outperform |
| 2020-05-29 | Bestätigt | Rosenblatt | Buy |
| 2020-05-29 | Bestätigt | UBS | Neutral |
| 2020-05-29 | Bestätigt | Wedbush | Outperform |
| 2020-04-24 | Herabstufung | SunTrust | Buy → Hold |
ZS
